James B. Bingham
Presidente presso Mmg Biopharmaceuticals Consulting LLC
Profilo
James B.
Bingham currently works at Mmg Biopharmaceuticals Consulting LLC, as President from 2008.
Dr. Bingham also formerly worked at Cambrex Corp., as Associate Director-Microbial Research from 2006 to 2007, Lonza, Inc., as Director-Research & Development, MedImmune LLC, as Principal, Human Genome Sciences, Inc., as Principal, Amplimmune, Inc., as Vice President-Development & Manufacturing from 2010 to 2015, Integrated Genetics, Inc., as Principal, and NextCure, Inc., as Chief Development Officer from 2018 to 2021.
Dr. Bingham received his doctorate degree from The Johns Hopkins University and undergraduate degree from St. Michael's College.
Posizioni attive di James B. Bingham
| Società | Posizione | Inizio |
|---|---|---|
Mmg Biopharmaceuticals Consulting LLC
 Mmg Biopharmaceuticals Consulting LLC Miscellaneous Commercial ServicesCommercial Services Mmg Biopharmaceuticals Consulting LLC is an American company that operates as a biopharmaceutical consulting firm. The private company is based in Vienna. | Presidente | 01/11/2008 |
Precedenti posizioni note di James B. Bingham
| Società | Posizione | Fine |
|---|---|---|
| NEXTCURE, INC. | Corporate Officer/Principal | 01/03/2021 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/07/2015 |
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2007 |
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Direttore Tecnico/Scientifico/R&S | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Formazione di James B. Bingham
| The Johns Hopkins University | Doctorate Degree |
| St. Michael's College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEXTCURE, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Health Technology |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
Mmg Biopharmaceuticals Consulting LLC
Mmg Biopharmaceuticals Consulting LLC Miscellaneous Commercial ServicesCommercial Services Mmg Biopharmaceuticals Consulting LLC is an American company that operates as a biopharmaceutical consulting firm. The private company is based in Vienna. | Commercial Services |
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Borsa valori
- Insiders
- James B. Bingham
